IBIO Trademark

Trademark Overview


On Wednesday, July 19, 2023, a trademark application was filed for IBIO with the United States Patent and Trademark Office. The USPTO has given the IBIO trademark a serial number of 98091758. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Monday, June 3, 2024. This trademark is owned by iBio, Inc. The IBIO trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical peptide, protein, antibody, and chimeric antibody or protein drug development services; Pharmaceutical peptide, protein, antibody, and chimeric antibodies or proteins product development; Pharmaceutical research and development of peptides, proteins, antibodies, and chimeric antibodies or proteins; Conducting early evaluations in the field of new peptide, protein, antibody, and chimeric antibody or protein based pharmaceuticals; Development of peptide, protein, antibody, and chimeric antibody or protein based pharmaceutical preparations and medicines; Laboratory peptide and protein based research services relating to pharmaceuticals; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Research and development of peptide, protein, antibody, and chimeric antibody or protein based pharmaceuticals for the treatment of age...
ibio

General Information


Serial Number98091758
Word MarkIBIO
Filing DateWednesday, July 19, 2023
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateMonday, June 3, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, July 9, 2024

Trademark Statements


Description of MarkThe mark consists of stylized word "IBIO", with the dot in the second "I" in the form of a double helix forming an infinity image, with arrow images in the interior of one side of the infinity form, and an image of carbons inside the other side of the infinity image.
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesPharmaceutical peptide, protein, antibody, and chimeric antibody or protein drug development services; Pharmaceutical peptide, protein, antibody, and chimeric antibodies or proteins product development; Pharmaceutical research and development of peptides, proteins, antibodies, and chimeric antibodies or proteins; Conducting early evaluations in the field of new peptide, protein, antibody, and chimeric antibody or protein based pharmaceuticals; Development of peptide, protein, antibody, and chimeric antibody or protein based pharmaceutical preparations and medicines; Laboratory peptide and protein based research services relating to pharmaceuticals; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Research and development of peptide, protein, antibody, and chimeric antibody or protein based pharmaceuticals for the treatment of age-related diseases and cancer; Research in the field of peptide, protein, antibody, and chimeric antibody or protein based pharmaceuticals; Research on the subject of peptide, protein, antibody, and chimeric antibody or protein based pharmaceuticals; Technical research in the field of peptide, protein, antibody, and chimeric antibody or protein based pharmaceutical studies; Testing, inspection or research of pharmaceuticals, cosmetics or foodstuff made with peptides, proteins, antibodies, and chimeric antibodies or proteins; Research and development in the pharmaceutical and biotechnology fields; Research and development regarding pharmaceuticals, proteins, and antibodies; platform-as-a-service (PaaS) featuring computer software platforms for protein analysis and discovery of antibody-based drugs; Software as a service (SAAS) services featuring software for designing molecule libraries for the purposes of generating products in the field of pharmaceuticals, biotechnology, and medicine; Computer software development in the field of artificial intelligence, biotechnology, pharmaceuticals, and medical applications; Laboratory research services relating to pharmaceuticals; Medical and scientific research in the field of cancer treatment and diagnosis; Providing information on the subject of scientific research in the field of biochemistry and biotechnology; Providing on-line non-downloadable software using artificial intelligence for use in facilitating product development in the field of biotechnology, pharmaceuticals, and medicine; Scientific research for medical purposes in the area of cancerous diseases; Software as a service (SAAS) services featuring software using artificial intelligence for use in facilitating product development in the field of biotechnology, pharmaceuticals, and medicine; Technical consulting in the field of pharmaceutical studies; Technology consultation in the field of artificial intelligence; Testing of pharmaceuticals; Testing, inspection or research of pharmaceuticals, cosmetics or foodstuff; Providing medical testing services and information in the field of cancer research and disease classification; Providing information about medical research in the field of artificial intelligence, medical biotechnology, and pharmaceuticals

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, August 17, 2023
Primary Code042
First Use Anywhere DateTuesday, July 11, 2023
First Use In Commerce DateTuesday, July 11, 2023

Trademark Owner History


Party NameiBio, Inc
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events


Event DateEvent Description
Saturday, July 22, 2023NEW APPLICATION ENTERED
Tuesday, August 1, 2023TEAS VOLUNTARY AMENDMENT RECEIVED
Thursday, August 17, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, August 18, 2023NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, December 28, 2023ASSIGNED TO LIE
Thursday, December 28, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, December 28, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, March 25, 2024ASSIGNED TO EXAMINER
Monday, April 8, 2024NON-FINAL ACTION E-MAILED
Monday, April 8, 2024NON-FINAL ACTION WRITTEN
Monday, April 8, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, April 26, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, April 26, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, May 30, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 19, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, April 26, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED